SEC Filing Summary: Prana Biotechnology Limited
Business Context and Reporting Period
This Form 6-K was filed by Prana Biotechnology Limited, a foreign private issuer based in South Melbourne, Australia, for the month of August 2007. The filing date is August 31, 2007. The registrant files annual reports under Form 20-F.
Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report is a notice of a change in interests of a substantial holder and does not contain financial statements or performance metrics.
Material Changes
The primary material change disclosed is a "Notice of Change of Interests of Substantial Holder." Specific details regarding the identity of the holder or the magnitude of the change are not included in the provided text.
Guidance, Outlook, and Risks
The filing text does not provide a clear value for guidance, outlook, management commentary, risks, contingencies, or unusual items. The document serves solely as a regulatory notification of the ownership change.
Key Facts for Investor Verification
- Verify the identity of the substantial holder whose interests changed.
- Confirm the specific percentage change in ownership and the resulting total holding.
- Check subsequent filings for any financial impact related to this ownership change.
- Note that the company name in the metadata (Altery Therapeutics Ltd) differs from the registrant name in the filing (Prana Biotechnology Limited).